The fallback procedure for evaluating a single family of hypotheses

Journal of Biopharmaceutical Statistics

Volumn 15, Issue 6, 2005, Pages 929-942

  Wiens, Brian L ^a,c   Dmitrienko, Alexei ^b  

^a AMGEN INC   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c Myogen Inc   (United States)

Author keywords

Bonferroni; Closed testing; Familywise error rate; Power; Type I error rate

Indexed keywords

ANALYTIC METHOD; ANALYTICAL ERROR; DATA ANALYSIS; FALLBACK PROCEDURE; HYPOTHESIS; MEDICAL RESEARCH; PRIORITY JOURNAL; REVIEW; STATISTICAL ANALYSIS;

DATA INTERPRETATION, STATISTICAL; ENDPOINT DETERMINATION; FALSE POSITIVE REACTIONS; PROBABILITY; RESEARCH DESIGN;

EID: 27544506961     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400500265660     Document Type: Review

References (25)

1. Bauer, P. (1991). Multiple testing in clinical trials. Stat. Med. 10:871-890.
2. Bauer, P., Röhmel, J., Maurer, W., Hothorn, L. (1998). Testing strategies in multi-dose experiments including active control. Stat. Med. 17:2133-2146.
3. Benjamini, Y., Hochberg, Y. (1997). Multiple hypothesis testing with weights. Scan. J. Stat. 24:407-418.
4. Chen, X., Luo, X., Capizzi, T. (2005a). The application of enhanced parallel gatekeeping strategies. Stat. Med. 24:1385-1397.
5. Chen, X., Capizzi, T., Binkowitz, B., Quan, H., Wei, L., Luo, E. (2005b). Decision rule based multiplicity adjustment strategy. Clin. Trials, in press.
6. Dmitrienko, A., Offen, W. W., Westfall, P. H. (2003). Gatekeeping strategies for clinical trials that do not require all primary effects to be significant. Stat. Med. 22:2387-2400.
7. Fisher, R. A. (1935). The Design and Analysis of Experiments. Edinburgh and London: Oliver & Boyd.
8. Grechanovsky, E., Hochberg, Y. (1999). Closed procedures are better and often admit a shortcut. J. Stat. Plann. Infer. 76:79-91.
9. Hartung, H. P., Gonsette, R., Konig, N., Kwiecinski, H., Guseo, A., Morrissey, S. P., Krapf, H., Zwingers, T. (2002). Mitoxantrone in multiple sclerosis study group. Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial. Lancet 360:2018-2025.
10. Hochberg, Y. (1988). A sharper Bonferroni procedure for multiple tests of significance. Biometrika 75:800-802.
11. Hochberg, Y., Tamhane, A. C. (1987). Multiple Comparison Procedures. New York: John Wiley & Sons.
12. Hochberg, Y., Liberman, U. (1994). An extended simes' test. Stat. Prob. Lett. 21:101-105.
13. Holm, S. (1979). A simple sequentially rejective multiple test procedure. Scan. J. Stat. 6:65-70.
14. Hommel, G. (1988). A stagewise rejective multiple test based on a modified Bonferroni test. Biometrika 75:383-386.
15. Hommel, G. (1989). A comparison of two modified Bonferroni procedures. Biometrika 76:624-625.
16. Lehmacher, W., Wassmer, G., Reitmeir, P. (1991). Procedures for two-sample comparisons with multiple endpoints controlling the experimentwise error rate. Biometrics 47:511-521.
17. Marcus, R., Peritz, E., Gabriel, K. R. (1976). On closed testing procedures with special reference to ordered analysis of variance. Biometrika 63:655-660.
18. Maurer, W., Hothorn, L., Lehmacher, W. (1995). Multiple comparisons in drug clinical trials and preclinical assays: a-priori ordered hypotheses. In: Vollmar, J., ed. Biometrie in der Chemisch-Pharmazeutischen Industrie, Vol. 6. Stuttgart: Fischer Verlag, pp. 3-18.
19. Pitt, B., Segal, R., Martinez, F. A., Meurers, G., Cowley, A. J., Thomas, I., Deedwania, P. C., Ney, D. E., Snavely, D. B., Chang, P. I., On behalf of ELITE Study Investigators. (1997). Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349:747-752.
20. Rosenthal, R., Rubin, D. B. (1983). Ensemble-adjusted p-values. Psychol. Bull. 94:540-541.
21. Simes, R. J. (1986). An improved Bonferroni procedure for multiple tests of significance. Biometrika 73:751-754.
22. Westfall, P. H., Krishen, A. (2001). Optimally weighted, fixed sequence and gatekeeper multiple testing procedures. J. Stat. Plann. Infer. 99:25-41.
23. Westfall, P., Bretz, F. (2003). Multiplicity in clinical trials. In: Shein-Chung Chow, ed. Encyclopedia of Biopharmaceutical Statistics, 2nd ed. New York: Marcel Decker Inc., pp. 666-673.
24. Wiens, B. (2003). A fixed sequence Bonferroni procedure for testing multiple endpoints. Pharma. Stat. 2:211-215.
25. Zhang, J., Quan, H., Ng, J., Stepanavage, M. E. (1997). Some statistical methods for multiple endpoints in clinical trials. Controll. Clin. Trials 18:204-221.